Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma

Overview of attention for article published in Frontiers in oncology, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 9,897 followers.

New article: Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma https://t.co/1yMdCpj3Kr #MMSM #MultipleMyeloma #hematology https://t.co/tvnA1ulvcf

01 Apr 2022

Reply Repost Favourite

RT @FrontOncology: 📄 New article: Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients Wi…

18 Mar 2022

Reply Repost Favourite

📄 New article: Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With #MultipleMyeloma 👨‍⚕️👩‍⚕️ Francesca Bonello (@Frances92292985) et al Read here 👉 https://t.co/VGeYeayJ1L @RobertoMinaMD @unito #My

18 Mar 2022

Reply Repost Favourite

New research: Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma: Background The anti-CD38 monoclonal antibody daratumumab is the backbone of most anti-multiple myeloma… https://t.c

14 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.